Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone

R. Tanosaki, H. Uchida, Y. Masuda, N. Michikawa, T. Ogawa, A. Kubo, Y. Ikeda

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0.6 mg/kg/day for a month, being significantly improved not only symptomatically and hematologically but also in bone marrow hematopoiesis. Although the effectiveness of PSL to restoration of bone marrow hematopoiesis has been almost unknown, long term oral PSL should be tried for a certain phase of IMF.

Original languageEnglish
Pages (from-to)256-258
Number of pages3
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Issue number2
Publication statusPublished - 1992 Feb

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone'. Together they form a unique fingerprint.

Cite this